Magro F - Search Results

1

Inflammatory Bowel Disease in Migrant Populations: Should we Look Even Further Back?

Fiorino G, Estevinho MM, Lopes DJM, Chersi F, Allocca M, Souto MT, Danese S, Magro F. Fiorino G, et al. Among authors: magro f. Curr Drug Targets. 2021;22(15):1706-1715. doi: 10.2174/1389450122666210203193817. Curr Drug Targets. 2021. PMID: 33538671 Review.

2

Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.

Veloso FT, Carvalho J, Magro F. Veloso FT, et al. Among authors: magro f. J Clin Gastroenterol. 1996 Jul;23(1):29-34. doi: 10.1097/00004836-199607000-00009. J Clin Gastroenterol. 1996. PMID: 8835896

3

Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

Magro F, Vieira-Coelho MA, Fraga S, Serrão MP, Veloso FT, Ribeiro T, Soares-da-Silva P. Magro F, et al. Dig Dis Sci. 2002 Jan;47(1):216-24. doi: 10.1023/a:1013256629600. Dig Dis Sci. 2002. PMID: 11837726

4

Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

Magro F, Araujo F, Pereira P, Meireles E, Diniz-Ribeiro M, Velosom FT. Magro F, et al. Dig Dis Sci. 2004 Aug;49(7-8):1265-74. doi: 10.1023/b:ddas.0000037822.55717.31. Dig Dis Sci. 2004. PMID: 15387356

5

Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment.

Magro F, Cunha E, Araujo F, Meireles E, Pereira P, Dinis-Ribeiro M, Veloso FT, Medeiros R, Soares-da-Silva P. Magro F, et al. Dig Dis Sci. 2006 Nov;51(11):2039-44. doi: 10.1007/s10620-006-9168-3. Epub 2006 Sep 15. Dig Dis Sci. 2006. PMID: 16977509

6

Inflammatory bowel disease: a patient's and caregiver's perspective.

Magro F, Portela F, Lago P, Deus J, Cotter J, Cremers I, Vieira A, Peixe P, Caldeira P, Lopes H, Gonçalves R, Reis J, Cravo M, Barros L, Ministro P, Lurdes Tavares M, Duarte A, Campos M, Carvalho L; Portuguese Study Group of IBD (GEDII); Association of Portuguese Patients with IBD (APDI). Magro F, et al. Dig Dis Sci. 2009 Dec;54(12):2671-9. doi: 10.1007/s10620-008-0658-3. Dig Dis Sci. 2009. PMID: 19130226

7

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F. Magro F, et al. BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.

8

How to manage pouchitis in ulcerative colitis?

Magro F, Lopes S, Rodrigues S, Azevedo I. Magro F, et al. Curr Drug Targets. 2011 Sep;12(10):1454-61. doi: 10.2174/138945011796818144. Curr Drug Targets. 2011. PMID: 21466487 Review.

9

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.

Peyrin-Biroulet L, Ferrante M, Magro F, Campbell S, Franchimont D, Fidder H, Strid H, Ardizzone S, Veereman-Wauters G, Chevaux JB, Allez M, Danese S, Sturm A; Scientific Committee of the European Crohn's and Colitis Organization. Peyrin-Biroulet L, et al. Among authors: magro f. J Crohns Colitis. 2011 Oct;5(5):477-83. doi: 10.1016/j.crohns.2011.06.009. Epub 2011 Aug 3. J Crohns Colitis. 2011. PMID: 21939925

10

Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.

Magro F, Santos-Antunes J, Albuquerque A, Vilas-Boas F, Macedo GN, Nazareth N, Lopes S, Sobrinho-Simões J, Teixeira S, Dias CC, Cabral J, Sarmento A, Macedo G. Magro F, et al. Inflamm Bowel Dis. 2013 Jul;19(8):1710-6. doi: 10.1097/MIB.0b013e318281f31c. Inflamm Bowel Dis. 2013. PMID: 23574759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page